Clinical Cardiology Assoc Melrose Park, IL - 60160

Clinical Cardiology Assoc is categorized under Cardiologists in Melrose Park, IL and active since 1985.

Clinical Cardiology Assoc was established in 1985, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Cardiologists business, which does work in the B2C market, and is classified as a Cardiologists, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Julie Farrell, Office Manager at the company’s single location by writing to 675 West North Avenue # 216, Melrose Park, Illinois IL 60160 or by phoning (708) 345-1618. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Clinical Cardiology Assoc
Contact Person: Julie Farrell, Office Manager
Address: 675 West North Avenue # 216, Melrose Park, Illinois 60160
Phone Number: (708) 345-1618
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 1985
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Cardiologists
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Clinical Cardiology Assoc was started in 1985 to provide professional Cardiologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Julie Farrell, Office Manager for inquiries that concern Clinical Cardiology Assoc by calling the company number (708) 345-1618, as your correspondence is most welcome. Additionally, the physical location of the single location of Clinical Cardiology Assoc can be found at the coordinates 41.908351,-87.842296 as well as the street address 675 West North Avenue # 216 in Melrose Park, Illinois 60160.

For its online presence, you may visit Clinical Cardiology Assoc’s website at and engage with its social media outlets through on Twitter and on Facebook.